These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 15613055)

  • 21. Clinical evaluation of the patient with bruising and bleeding.
    Taylor RE; Blatt PM
    J Am Acad Dermatol; 1981 Mar; 4(3):348-68. PubMed ID: 7012204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of the bleeding time in the neonatal intensive care unit.
    Del Vecchio A
    Acta Paediatr Suppl; 2002; 91(438):82-6. PubMed ID: 12477268
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The platelet function analyzer (PFA-100): an update on its clinical use.
    Franchini M
    Clin Lab; 2005; 51(7-8):367-72. PubMed ID: 16122146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. External quality assessment/proficiency testing and internal quality control for the PFA-100 and PFA-200: an update.
    Favaloro EJ; Bonar R
    Semin Thromb Hemost; 2014 Mar; 40(2):239-53. PubMed ID: 24497116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet function analyzer (PFA-100): a tool to quantify congenital or acquired platelet dysfunction.
    Jilma B
    J Lab Clin Med; 2001 Sep; 138(3):152-63. PubMed ID: 11528368
    [No Abstract]   [Full Text] [Related]  

  • 26. Congenital disorders of platelet function.
    Weiss HJ
    Semin Hematol; 1980 Oct; 17(4):228-41. PubMed ID: 7003719
    [No Abstract]   [Full Text] [Related]  

  • 27. The clinical manifestations of bleeding.
    Schwartz SO
    Med Clin North Am; 1972 Jan; 56(1):17-24. PubMed ID: 4536634
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparison of PFA-100 and bleeding time testing in pediatric patients with suspected hemorrhagic problems.
    Cariappa R; Wilhite TR; Parvin CA; Luchtman-Jones L
    J Pediatr Hematol Oncol; 2003 Jun; 25(6):474-9. PubMed ID: 12794526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison Between Bleeding Time and PFA-200 to Evaluate Platelet Function Disorder in Children.
    Srichumpuang C; Sosothikul D
    J Pediatr Hematol Oncol; 2021 Jul; 43(5):e748-e749. PubMed ID: 34157013
    [No Abstract]   [Full Text] [Related]  

  • 30. The platelet-function analyzer (PFA-100) for evaluating primary hemostasis.
    Franchini M
    Hematology; 2005 Jun; 10(3):177-81. PubMed ID: 16019466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of the PFA-100 in the assessment of primary, platelet-related hemostasis in a pediatric setting.
    Rand ML; Carcao MD; Blanchette VS
    Semin Thromb Hemost; 1998; 24(6):523-9. PubMed ID: 10066147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utility of the PFA-100 for assessing bleeding disorders and monitoring therapy: a review of analytical variables, benefits and limitations.
    Favaloro EJ
    Haemophilia; 2001 Mar; 7(2):170-9. PubMed ID: 11260277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rational use of the PFA-100 device for screening of platelet function disorders and von Willebrand disease.
    Buyukasik Y; Karakus S; Goker H; Haznedaroglu IC; Ozatli D; Sayinalp N; Ozcebe OI; Dundar SV; Kirazli S
    Blood Coagul Fibrinolysis; 2002 Jun; 13(4):349-53. PubMed ID: 12032401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A diagnostic approach to mild bleeding disorders.
    Boender J; Kruip MJ; Leebeek FW
    J Thromb Haemost; 2016 Aug; 14(8):1507-16. PubMed ID: 27208505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Problems of haemostasis and coagulation. Diagnostic orientation].
    Bezeaud A; Guillin MC; Fischer AM
    Rev Prat; 2007 Feb; 57(3):327-35. PubMed ID: 17578036
    [No Abstract]   [Full Text] [Related]  

  • 36. Platelet function testing: from routine to specialist testing.
    Gurney D
    Br J Biomed Sci; 2016; 73(1):10-20. PubMed ID: 27182671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Time for a conceptual shift in assessment of internal quality control for whole blood or cell-based testing systems? An evaluation using platelet function and the PFA-100 as a case example.
    Favaloro EJ
    Clin Chem Lab Med; 2013 Apr; 51(4):767-74. PubMed ID: 23152413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of PFA-100 testing in the investigation and management of haemostatic defects in children and adults.
    Harrison P
    Br J Haematol; 2005 Jul; 130(1):3-10. PubMed ID: 15982339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Physiological review of hemostasis].
    Launay F
    Neurochirurgie; 1973; 19(3):259-64. PubMed ID: 4547605
    [No Abstract]   [Full Text] [Related]  

  • 40. Update on diagnostic testing for platelet function disorders: What is practical and useful?
    Hayward CPM; Moffat KA; Brunet J; Carlino SA; Plumhoff E; Meijer P; Zehnder JL
    Int J Lab Hematol; 2019 May; 41 Suppl 1():26-32. PubMed ID: 31069975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.